Thermo Fisher and Xcell Biosciences Partner to Advance TIL and Treg Cell Therapies

Thermo Fisher Scientific Inc. (NYSE:TMO) ranks among the best CRISPR stocks to buy. On June 24, Thermo Fisher Scientific Inc. (NYSE:TMO) partnered with Xcell Biosciences, an instrumentation firm specializing in cell and gene therapy applications, to advance research on tumor-infiltrating lymphocytes (TILs) and regulatory T cells (Tregs).

While an extensive amount of progress has been achieved on the subject of cell therapy using Chimeric Antigen Receptor T (CAR T) cells, the primary objective of this collaboration is to develop Treg and TIL cell therapies that are specifically designed to fight solid tumors and autoimmune diseases.

Thermo Fisher and Xcell Biosciences Partner to Advance TIL and Treg Cell Therapies

The collaboration also aims to increase scalability and consistency in cell therapy production while streamlining operations to assist patients in having more access to these vital treatments.

Speaking on this partnership, Thermo Fisher Scientific Inc. (NYSE:TMO)’s senior director of research and development, Andy Campbell, stated the following:

“We are confident that this collaboration will significantly shorten and enhance the manufacturing workflow for cell therapies in this space, ultimately helping our customers make the world a healthier place.”

Thermo Fisher Scientific Inc. (NYSE:TMO) serves a variety of global markets with a broad range of products and services related to analytical instruments, specialty diagnostics, life sciences solutions, and laboratory supplies. The company also offers an array of genome editing solutions, such as guide RNA (gRNA), mRNA, plasmids, and CRISPR proteins.

While we acknowledge the potential of TMO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

Read More: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds

Disclosure: None.